PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 18, 2003Circulation659 citations

Clinical Characterization of Left Ventricular Noncompaction in Children

View Full Paper
RPRicardo H. PignatelliCMColin J. McMahonWDWilliam J. Dreyer

Structured PICO

P
Population
36 children with left ventricular noncompaction (LVNC) evaluated at Texas Children's Hospital, median age 90 days, 16 girls and 20 boys.
O
Outcome
Clinical characteristics and outcomes including mortality and ventricular function changes

In children with left ventricular noncompaction, the clinical course is not invariably fatal, and some patients exhibit a transient recovery of ventricular function followed by later deterioration.

Abstract

BACKGROUND: Left ventricular noncompaction (LVNC) is a reportedly uncommon genetic disorder of endocardial morphogenesis with a reportedly high mortality rate. The purpose of this study was to identify the clinical characteristics of children with LVNC. METHODS AND RESULTS: We retrospectively reviewed 36 children with LVNC evaluated at Texas Children's Hospital (TCH) from January 1997 to December 2002. Five children had associated cardiac lesions. There were 16 girls and 20 boys. The median age at presentation was 90 days (range, 1 day to 17 years). The median duration of follow-up was 3.2 years (range, 0.5 to 12 years). Twenty-seven patients (75%) had ECG abnormalities, most commonly biventricular hypertrophy (10 patients, 28%). Both ventricles were involved in 8 patients (22%) and only the left ventricle in 28 patients (78%). Left ventricular systolic function was depressed in 30 patients (83%), with a median ejection fraction of 30% (range, 15% to 66%) at diagnosis. Nine patients presenting in the first year of life with depressed left ventricular contractility had a transient recovery of function; however, ejection fraction deteriorated later in life, at a median interval of 6.3years (range, 3 to 12 years). Two patients had an "undulating" phenotype from dilated to hypertrophic cardiomyopathy. Two patients (6%) were identified with an underlying G4.5 gene mutation. Five patients (14%) died during the study. CONCLUSIONS: LVNC does not have an invariably fatal course when diagnosed in the neonatal period. A significant number of patients have transient recovery of function followed by later deterioration, which may account for many patients presenting as adults, some manifesting an "undulating" phenotype.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pignatelli et al. (2003) studied this question.

synapsesocial.com/papers/69fd26b8ff035021982700edhttps://doi.org/10.1161/01.cir.0000100664.10777.b8
Ask AI
Helpful
Bookmark
Share
View Full Paper